维生素D补充对非骨骼疾病的影响:系统综述
该系统综述检索了2013年1月1日至2017年5月31日发表的维生素D补充与非骨骼疾病的荟萃分析及未纳入荟萃分析的随机试验,发现每日10-20 μg维生素D可降低中老年人全因死亡率和癌症死亡率,但无新证据支持其对多数非骨骼疾病有效,仅可能有助于预防常见上呼吸道感染和哮喘急性发作。
要点
- 每日10-20 μg维生素D可降低中老年人全因死亡率和癌症死亡率。
- 无新证据显示维生素D补充对心血管疾病、肥胖、糖代谢、情绪障碍等非骨骼疾病有效。
- 维生素D补充可能有助于预防常见上呼吸道感染和哮喘急性发作。
核心结论
- 近期荟萃分析强化了每日10-20 μg维生素D可降低中老年人全因死亡率和癌症死亡率的发现。
- 无新证据表明维生素D补充对多数非骨骼疾病有效,仅可能有助于预防常见上呼吸道感染和哮喘急性发作。
- 低维生素D状态可能是健康不良的结果而非原因。
研究设计与样本
- 系统综述纳入2013年1月1日至2017年5月31日发表的维生素D补充与非骨骼疾病的荟萃分析,涵盖所有年龄段参与者包括孕妇,并检索未纳入荟萃分析的随机试验。
- 共识别87项荟萃分析,排除52项因文献较旧或质量欠佳,另检索到202篇未纳入荟萃分析的试验文章。
- 汇总83项试验的结果分析维生素D补充对全身炎症生物标志物的影响。
主要发现
- 每日10-20 μg维生素D可降低中老年人全因死亡率和癌症死亡率。
- 无新证据显示维生素D补充对心血管疾病、肥胖、糖代谢、情绪障碍、肌肉功能、结核、结直肠腺瘤或母婴围产期状况有影响。
- 83项试验汇总显示维生素D补充对全身炎症生物标志物无显著影响。
- 新发现提示维生素D补充可能有助于预防常见上呼吸道感染和哮喘急性发作。
- 癌症结局的新数据稀少。
关键数值与推荐
- 每日10-20 μg维生素D可降低中老年人全因死亡率和癌症死亡率。
- 83项试验汇总显示维生素D补充对全身炎症生物标志物无显著影响。
临床怎么用
- 原文未据此给出推荐。
局限性
- 识别出许多质量欠佳的荟萃分析,令人担忧。
- 癌症结局的新数据稀少。
- 未来的维生素D系统综述应基于数据共享,以便将相同结局以相同方式测量的参与者数据合并以产生更强证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Randomised trials reported up to Dec 31, 2012, did not confirm that vitamin D supplementation could protect from non-skeletal health conditions affecting adults, as was expected on the basis of data from observational studies. To examine whether the more recently published meta-analyses and trials would change past conclusions, we systematically reviewed meta-analyses of vitamin D supplementation and non-skeletal disorders published between Jan 1, 2013, and May 31, 2017, that included study participants of all ages, including pregnant women. We also searched for randomised trials not included in meta-analyses. We identified 87 meta-analyses, of which 52 were excluded because they contained less recent literature or were of suboptimal quality. We retrieved 202 articles on trials that were not included in meta-analyses. Recent meta-analyses reinforce the finding that 10-20 μg per day of vitamin D can reduce all-cause mortality and cancer mortality in middle-aged and older people. Although vitamin D doses were greater than those assessed in the past, we found no new evidence that supplementation could have an effect on most non-skeletal conditions, including cardiovascular disease, adiposity, glucose metabolism, mood disorders, muscular function, tuberculosis, and colorectal adenomas, or on maternal and perinatal conditions. New data on cancer outcomes were scarce. The compilation of results from 83 trials showed that vitamin D supplementation had no significant effect on biomarkers of systemic inflammation. The main new finding highlighted by this systematic review is that vitamin D supplementation might help to prevent common upper respiratory tract infections and asthma exacerbations. There remains little evidence to suggest that vitamin D supplementation has an effect on most conditions, including chronic inflammation, despite use of increased doses of vitamin D, strengthening the hypothesis that low vitamin D status is a consequence of ill health, rather than its cause. We further hypothesise that vitamin D supplementation could exert immunomodulatory effects that strengthen resistance to acute infections, which would reduce the risk of death in debilitated individuals. We identified many meta-analyses of suboptimal quality, which is of concern. Future systematic reviews on vitamin D should be based on data sharing so that data for participants with the same outcomes measured in the same way can be pooled to generate stronger evidence.
引用
- Autier P, Mullie P, Macacu A, et al. Effect of vitamin D supplementation on non-skeletal disorders: a systematic review of meta-analyses and randomised trials. Lancet Diabetes Endocrinol. 2017. PMID: 29102433. doi:10.1016/S2213-8587(17)30357-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。